294 related articles for article (PubMed ID: 26360322)
1. Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11.
Nielsen LM; Holm NB; Olsen L; Linnet K
Drug Test Anal; 2016 Aug; 8(8):792-800. PubMed ID: 26360322
[TBL] [Abstract][Full Text] [Related]
2. CYP3A4 Mediates Oxidative Metabolism of the Synthetic Cannabinoid AKB-48.
Holm NB; Nielsen LM; Linnet K
AAPS J; 2015 Sep; 17(5):1237-45. PubMed ID: 26002511
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.
Chimalakonda KC; Seely KA; Bratton SM; Brents LK; Moran CL; Endres GW; James LP; Hollenberg PF; Prather PL; Radominska-Pandya A; Moran JH
Drug Metab Dispos; 2012 Nov; 40(11):2174-84. PubMed ID: 22904561
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.
Wiley JL; Marusich JA; Lefever TW; Grabenauer M; Moore KN; Thomas BF
Neuropharmacology; 2013 Dec; 75():145-54. PubMed ID: 23916483
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans.
Watanabe S; Kuzhiumparambil U; Nguyen MA; Cameron J; Fu S
AAPS J; 2017 Jul; 19(4):1148-1162. PubMed ID: 28455676
[TBL] [Abstract][Full Text] [Related]
6. In vitro metabolism of a novel synthetic cannabinoid, EAM-2201, in human liver microsomes and human recombinant cytochrome P450s.
Kim JH; Kim HS; Kong TY; Lee JY; Kim JY; In MK; Lee HS
J Pharm Biomed Anal; 2016 Feb; 119():50-8. PubMed ID: 26641707
[TBL] [Abstract][Full Text] [Related]
7. Determination of urinary metabolites of XLR-11 by liquid chromatography-quadrupole time-of-flight mass spectrometry.
Jang M; Kim IS; Park YN; Kim J; Han I; Baeck S; Yang W; Yoo HH
Anal Bioanal Chem; 2016 Jan; 408(2):503-16. PubMed ID: 26514671
[TBL] [Abstract][Full Text] [Related]
8. Identification of the human cytochrome P450 isoforms mediating in vitro N-dealkylation of perphenazine.
Olesen OV; Linnet K
Br J Clin Pharmacol; 2000 Dec; 50(6):563-71. PubMed ID: 11136295
[TBL] [Abstract][Full Text] [Related]
9. Metabolic characterization of (1-(5-fluoropentyl)-1H-indol-3-yl)(4-methyl-1-naphthalenyl)-methanone (MAM-2201) using human liver microsomes and cDNA-overexpressed cytochrome P450 enzymes.
Kong TY; Kim JH; Choi WG; Lee JY; Kim HS; Kim JY; In MK; Lee HS
Anal Bioanal Chem; 2017 Feb; 409(6):1667-1680. PubMed ID: 27924364
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice.
He W; Wu JJ; Ning J; Hou J; Xin H; He YQ; Ge GB; Xu W
Toxicol In Vitro; 2015 Oct; 29(7):1569-76. PubMed ID: 26100226
[TBL] [Abstract][Full Text] [Related]
11. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids.
Sobolevsky T; Prasolov I; Rodchenkov G
Drug Test Anal; 2012 Oct; 4(10):745-53. PubMed ID: 23042760
[TBL] [Abstract][Full Text] [Related]
12. In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studies.
Wang L; Zhang D; Raghavan N; Yao M; Ma L; Frost CE; Maxwell BD; Chen SY; He K; Goosen TC; Humphreys WG; Grossman SJ
Drug Metab Dispos; 2010 Mar; 38(3):448-58. PubMed ID: 19940026
[TBL] [Abstract][Full Text] [Related]
13. Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies.
Ericsson T; Sundell J; Torkelsson A; Hoffmann KJ; Ashton M
Xenobiotica; 2014 Jul; 44(7):615-26. PubMed ID: 24400699
[TBL] [Abstract][Full Text] [Related]
14. First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry.
Wohlfarth A; Pang S; Zhu M; Gandhi AS; Scheidweiler KB; Liu HF; Huestis MA
Clin Chem; 2013 Nov; 59(11):1638-48. PubMed ID: 24014837
[TBL] [Abstract][Full Text] [Related]
15. JWH-018 ω-OH, a shared hydroxy metabolite of the two synthetic cannabinoids JWH-018 and AM-2201, undergoes oxidation by alcohol dehydrogenase and aldehyde dehydrogenase enzymes in vitro forming the carboxylic acid metabolite.
Holm NB; Noble C; Linnet K
Toxicol Lett; 2016 Sep; 259():35-43. PubMed ID: 27421777
[TBL] [Abstract][Full Text] [Related]
16. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
[TBL] [Abstract][Full Text] [Related]
17. Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism.
Moody DE; Liu F; Fang WB
J Anal Toxicol; 2015 Jun; 39(5):374-86. PubMed ID: 25868557
[TBL] [Abstract][Full Text] [Related]
18. In vitro Inhibitory Effects of Cynaroside on Human Liver Cytochrome P450 Enzymes.
Wang L; Ma X; Wang J; Li C
Pharmacology; 2019; 104(5-6):296-302. PubMed ID: 31587003
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes.
Lang J; Li W; Zhao J; Wang K; Chen D
Xenobiotica; 2017 Oct; 47(10):849-855. PubMed ID: 27819189
[TBL] [Abstract][Full Text] [Related]
20. Enantioselective inhibition of Cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: Major effect on CYP2B6.
Bhateria M; Ramakrishna R; Puttrevu SK; Saxena AK; Bhatta RS
Chem Biol Interact; 2016 Aug; 256():257-65. PubMed ID: 27387538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]